ASTH vs SGRY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

ASTH

49.3
AI Score
VS
SGRY Wins

SGRY

59.5
AI Score

Investment Advisor Scores

ASTH

49score
Recommendation
HOLD

SGRY

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ASTH SGRY Winner
Revenue 1.94B 417.37M ASTH
Net Income 34.17M -17.50M ASTH
Net Margin 1.8% -4.2% ASTH
Operating Income 62.85M 41.20M ASTH
ROE 4.1% -2.8% ASTH
ROA 1.5% -0.4% ASTH
Total Assets 2.28B 4.59B SGRY
Cash 400.79M 112.82M ASTH
Current Ratio 1.23 1.72 SGRY
Free Cash Flow 92.93M 20.00M ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: +6.1% · 3M: -4.7% SGRY 1M: -6.1% · 3M: -3.7%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $37.98

SGRY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $14.38

Fundamentals Snapshot

Metric ASTH SGRY
Market Cap
Forward P/E 10.7 22.9
Trailing P/E 46.4
Revenue (TTM)
Revenue Growth 0.5% 0.0%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.1%
EPS 0.82 -0.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SGRY is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.